Schedule 13G ownership disclosure

Scinai Immunotherapeutics Ltd.

American Depository Shares, each representing 4,000 Ordinary Shares, no par value · CUSIP: 09073Q203

Event date: 2025-03-24

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • YA II PN, Ltd.

    Shares: 93,274.00 · Class: 9.9%

  • YA Global Investments II (U.S.), LP

    Shares: 93,274.00 · Class: 9.9%

  • Yorkville Advisors Global, LP

    Shares: 93,274.00 · Class: 9.9%

  • Yorkville Advisors Global II, LLC

    Shares: 93,274.00 · Class: 9.9%

  • YAII GP, LP

    Shares: 93,274.00 · Class: 9.9%

  • YAII GP II, LLC

    Shares: 93,274.00 · Class: 9.9%

  • Mark Angelo

    Shares: 93,274.00 · Class: 9.9%

  • SC-Sigma Global Partners, LP

    Shares: 93,274.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-028313
Form type
SCHEDULE 13G
Filer
Scinai Immunotherapeutics Ltd.
CIK
CIK 1611747
Filed
Mar 26, 2025
Reporting period
Mar 24, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub